Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Titel:
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Auteur:
Kantarjian, Hagop M Roboz, Gail J Kropf, Patricia L Yee, Karen W L O'Connell, Casey L Tibes, Raoul Walsh, Katherine J Podoltsev, Nikolai A Griffiths, Elizabeth A Jabbour, Elias Garcia-Manero, Guillermo Rizzieri, David Stock, Wendy Savona, Michael R Rosenblat, Todd L Berdeja, Jesus G Ravandi, Farhad Rock, Edwin P Hao, Yong Azab, Mohammad Issa, Jean-Pierre J